XML 93 R75.htm IDEA: XBRL DOCUMENT v3.23.1
Note 11 - Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Sep. 30, 2022
Accumulated Amortization $ (22,010) $ (12,313)  
Net Carrying Value 32,088    
Total intangible assets, gross 54,098 164,462  
Total intangible assets, net $ 32,088 $ 152,149  
Weighted Average [Member]      
Weighted Average Useful Life (Year) 8 years 2 months 12 days 9 years 9 months 18 days  
Customer Relationships [Member]      
Gross Carrying Value $ 11,288 $ 17,516  
Accumulated Amortization (3,993) (1,776)  
Net Carrying Value $ 7,295 $ 15,740 $ 16,000
Customer Relationships [Member] | Weighted Average [Member]      
Weighted Average Useful Life (Year) 9 years 3 months 18 days 10 years 3 months 18 days  
Trade Names [Member]      
Gross Carrying Value $ 13,731 $ 35,574  
Accumulated Amortization (4,323) (2,306)  
Net Carrying Value $ 9,408 $ 33,268 29,600
Trade Names [Member] | Weighted Average [Member]      
Weighted Average Useful Life (Year) 12 years 9 months 18 days 13 years 9 months 18 days  
Technology-Based Intangible Assets [Member]      
Gross Carrying Value $ 27,892 $ 41,942  
Accumulated Amortization (12,796) (7,789)  
Net Carrying Value $ 15,096 $ 34,153 38,400
Technology-Based Intangible Assets [Member] | Weighted Average [Member]      
Weighted Average Useful Life (Year) 4 years 10 months 24 days 5 years 10 months 24 days  
Noncompete Agreements [Member]      
Gross Carrying Value $ 1,187 $ 1,990  
Accumulated Amortization (898) (442)  
Net Carrying Value $ 289 $ 1,548 $ 2,000
Noncompete Agreements [Member] | Weighted Average [Member]      
Weighted Average Useful Life (Year) 2 years 3 years  
In Process Research and Development [Member]      
Gross Carrying Value [1]   $ 67,440  
Accumulated Amortization [1]   0  
Net Carrying Value [1]   $ 67,440  
[1] In-process R&D represents the fair value of incomplete research and development that has not yet reached technological feasibility. Per discussion below, this balance has been written off as a result of the impairment analyses performed during the second and fourth quarters of the year ended December 31, 2022.